Accrued Liabilities - Novogene Co Ltd (SSE:688315) - Alpha Spread

Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 9.15 CNY -3.17%
Market Cap: 3.8B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Novogene Co Ltd
Accrued Liabilities Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Accrued Liabilities
ÂĄ132.6m
CAGR 3-Years
5%
CAGR 5-Years
23%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Accrued Liabilities
ÂĄ2.2B
CAGR 3-Years
10%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Accrued Liabilities
ÂĄ732.6m
CAGR 3-Years
17%
CAGR 5-Years
28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Accrued Liabilities
ÂĄ346m
CAGR 3-Years
30%
CAGR 5-Years
27%
CAGR 10-Years
38%
Genscript Biotech Corp
HKEX:1548
Accrued Liabilities
$165.9m
CAGR 3-Years
11%
CAGR 5-Years
34%
CAGR 10-Years
N/A

See Also

What is Novogene Co Ltd's Accrued Liabilities?
Accrued Liabilities
132.6m CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Accrued Liabilities amounts to 132.6m CNY.

What is Novogene Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
23%

Over the last year, the Accrued Liabilities growth was 1%. The average annual Accrued Liabilities growth rates for Novogene Co Ltd have been 5% over the past three years , 23% over the past five years .

Back to Top